Behavioral reactivity to acute stress among Black and White women with type 2 diabetes: The roles of income and racial discrimination

2016 ◽  
Vol 21 (9) ◽  
pp. 2085-2097 ◽  
Author(s):  
Angela Bermudez-Millan ◽  
Kristina P Schumann ◽  
Richard Feinn ◽  
Howard Tennen ◽  
Julie Wagner
2018 ◽  
Vol 53 (4) ◽  
pp. 309-320 ◽  
Author(s):  
Laura Panagi ◽  
Lydia Poole ◽  
Ruth A Hackett ◽  
Andrew Steptoe

Circulation ◽  
2012 ◽  
Vol 125 (suppl_10) ◽  
Author(s):  
Jill Dreyfus ◽  
Pamela J Schreiner ◽  
Mercedes R Carnethon ◽  
Hilary Whitham ◽  
Richard Maclehose ◽  
...  

Introduction: Recent studies report an association between early age at menarche and risk of type 2 diabetes (T2D). However, information in young women is limited to self-reported diabetes in primarily white populations. We explored the association of age at menarche and clinically-defined T2D among young black and white women (mean age 25 at baseline) in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort. Hypothesis: We assessed the hypothesis that the rate for T2D will decrease with each 1 year increase in age at menarche. Methods: Our analysis included 1,258 white and 1,341 black women (total=2,599) who participated in CARDIA during 1985-2006. We used Cox proportional hazards models to estimate hazard ratios (HR) for T2D (yes/no as determined at clinic visits) by continuous age at menarche. We excluded women with diabetes at baseline, missing age at menarche, or menarche <8 or >18 years. T2D was defined cumulatively from baseline among non-pregnant women as fasting blood glucose ≥ 126 mg/dl, A1C ≥ 6.5%, 2-hour oral glucose tolerance ≥ 200 mg/dl, or use of diabetes medication. Adjusted models included race (except race stratified models) and parental history of diabetes, as well as baseline age, education, and BMI as covariates. Results: Mean age at menarche was 12.6 years (SD=1.5; black=12.5, white=12.7). We identified 176 cases of T2D over 20 years of follow-up (cumulative incidence=6.8%). Among all women, the rate for T2D decreased by 16% for each 1 year increase in menarche age ( Table 1 ); we found no evidence of nonlinearity. HRs remained protective, but no longer statistically significant after adjustment for BMI. HRs were lower for white women compared to black women, although a test for race by menarche age interaction was not significant (p=0.26). Conclusions: We found evidence to support the hypothesis that early menarche increases the rate for T2D among young women. Higher baseline BMI among women with earlier menarche appears to attenuate the association of age at menarche and future glucose metabolism. Table 1. Hazard Ratio (HR) of Type 2 Diabetes for Each One Year Increase in Age at Menarche in the CARDIA Study, 1985-2006 Crude Model 1 Model 2 # T2D HR 95% CI HR 95% CI HR 95% CI All Women 176 0.84 0.76, 0.93 0.88 0.79, 0.98 0.94 0.85, 1.04 White 46 0.78 0.64, 0.96 0.83 0.68, 1.02 0.93 0.76, 1.16 Black 130 0.90 0.80, 1.01 0.90 0.80, 1.02 0.96 0.85, 1.08 Model 1: adjusted for race (except for race-stratified models), family history of diabetes, baseline age, and participant level of education at baseline (<HS, HS, >HS) Model 2: adjusted for variables in Model 1 plus baseline BMI


2020 ◽  
Vol 8 (1) ◽  
pp. e000850 ◽  
Author(s):  
Mengying Li ◽  
Mohammad L Rahman ◽  
Jing Wu ◽  
Ming Ding ◽  
Jorge E Chavarro ◽  
...  

ObjectiveWomen with a history of gestational diabetes mellitus (GDM) have an exceptionally high risk for type 2 diabetes (T2D). Yet, little is known about genetic determinants for T2D in this population. We examined the association of a genetic risk score (GRS) with risk of T2D in two independent populations of women with a history of GDM and how this association might be modified by non-genetic determinants for T2D.Research design and methodsThis cohort study included 2434 white women with a history of GDM from the Nurses’ Health Study II (NHSII, n=1884) and the Danish National Birth Cohort (DNBC, n=550). A GRS for T2D was calculated using 59 candidate single nucleotide polymorphisms for T2D identified from genome-wide association studies in European populations. An alternate healthy eating index (AHEI) score was derived to reflect dietary quality after the pregnancy affected by GDM.ResultsWomen on average were followed for 21 years in NHSII and 13 years in DNBC, during which 446 (23.7%) and 155 (28.2%) developed T2D, respectively. The GRS was generally positively associated with T2D risk in both cohorts. In the pooled analysis, the relative risks (RRs) for increasing quartiles of GRS were 1.00, 0.97, 1.25 and 1.19 (p trend=0.02). In both cohorts, the association appeared to be stronger among women with poorer (AHEI <median) than better dietary quality (AHEI ≥median), although the interaction was not significant. For example, in NHSII, the RRs across increasing quartiles of GRS were 1.00, 0.99, 1.51 and 1.29 (p trend=0.06) among women with poorer dietary quality and 1.00, 0.83, 0.81 and 0.94 (p trend=0.79) among women with better dietary quality (p interaction=0.11).ConclusionsAmong white women with a history of GDM, higher GRS for T2D was associated with an increased risk of T2D.


2018 ◽  
Vol 28 (1) ◽  
pp. 25 ◽  
Author(s):  
Olayinka O. Shiyanbola ◽  
Earlise Ward ◽  
Carolyn Brown

<p class="Pa7"><strong>Objective: </strong>Illness representations, known as patients’ beliefs and expectations about an illness, may be influenced by cultural beliefs and personal experiences. This study explored African Americans’ perceptions of the sociocultural factors that influence their representations of diabetes.</p><p class="Pa7"><strong>Design: </strong>Six semi-structured focus groups.</p><p class="Pa7"><strong>Setting: </strong>Private space at a convenient site.</p><p class="Pa7"><strong>Participants: </strong>Forty African Americans, aged 45-60 years with type 2 diabetes for at least one year prior.</p><p class="Pa7"><strong>Results: </strong>Participants perceived that there was a race-mediated effect of how they developed diabetes because of poverty due to past slavery, racial discrimination by health care providers, and the stigma associated with diabetes within the African American community. Participants perceived that pov­erty influenced African Americans’ unhealthy eating habits, which led to diabetes diagnosis among their ancestors and their develop­ment of the disease since it was hereditary. Participants also perceived that there was provider ill intention, ie, providers were pur­posefully making people sick, and their lack of education on diabetes from providers was done on purpose, as information on diabetes was withheld and not shared due to racial discrimination. Perceived stigma by the com­munity led to African Americans’ avoidance and denial of the disease, and subsequently the development of diabetes.</p><p class="Pa7"><strong>Conclusions: </strong>To enhance disease manage­ment for African Americans with diabetes, it is important to focus on the sociocultural context of how African Americans view their world that may be influenced by their knowl­edge of negative historical circumstances and their current provider relationship, which, in turn, may be reflected in their perceptions of diabetes.</p><p class="Pa7"><em>Ethn Dis. </em>2018;28(1):25-32; doi:10.18865/ed.28.1.25.</p>


2014 ◽  
Vol 19 (7) ◽  
pp. 1526-1534 ◽  
Author(s):  
Joyce W. Tang ◽  
Krys E. Foster ◽  
Javiera Pumarino ◽  
Ronald T. Ackermann ◽  
Alan M. Peaceman ◽  
...  

Author(s):  
Nkiru Umekwe ◽  
Ibiye Owei ◽  
Frankie Stentz ◽  
Sam Dagogo-Jack

Abstract Increased circulating fibroblast growth factor (FGF)-21 and sclerostin levels have been reported in patients with type 2 diabetes (T2D). We assessed the association of FGF-21 and sclerostin with adiposity, glycemia and glucoregulatory measures in healthy subjects. We studied 20 normoglycemic Black and White offspring of parents with T2D. Assessments included OGTT, insulin sensitivity (Si-clamp), insulin secretion (HOMA-B), and body fat (DXA). Fasting plasma FGF-21 and sclerostin levels were measured with ELISAs. The participants' mean (+SD) age was 50.4 ± 5.97 yr; BMI 32.5 ± 5.86 kg/m2; fasting plasma glucose (FPG) 96.1 ± 5.21 mg/dl, and 2-hr post-load glucose (2hPG) 116 ± 5.45 mg/dl. FGF-21 levels were similar in Blacks vs. Whites (0.36 ± 0.15 ng/ml vs. 0.39 ± 0.25 ng/ml), men vs. women (0.45 ± 0.14 vs. 0.44 ± 0.07ng/ml), correlated positively with body mass index (BMI) (r=0.23, P=0.05) and waist circumference (r=0.27, P=0.04), and inversely with FPG (r= -0.26, P=0.05). Sclerostin levels also were similar in Blacks (33.5 ± 17.1 pmol/l) vs. Whites (34.2 ± 6.41 pmol/l), men vs. women (35.3 ± 9.01 pmol/l vs. 32.3 ± 15.8 pmol/l), and correlated inversely with FPG (r= - 0.11-0.44) but not adiposity measures. The correlation coefficient between Si-clamp values and FGF-21 levels was -0.31 (P=0.09) compared with 0.04 (P=0.89) for sclerostin levels. FGF-21 and sclerostin levels were not correlated with each other or HOMA-B. Among healthy Black and White subjects, plasma FGF-21 and sclerostin showed differential associations with adiposity but concordant association with FPG levels.


Sign in / Sign up

Export Citation Format

Share Document